English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Meeting Abstract

GLINT GlucoCEST in neoplastic tumours at 3T: the first clinical results of GlucoCEST in brain tumours

MPS-Authors
/persons/resource/persons216054

Lindig,  T
Institutional Guests, Max Planck Institute for Biological Cybernetics, Max Planck Society;

/persons/resource/persons216025

Herz,  K
Department High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Max Planck Society;

/persons/resource/persons215996

Deshmane,  A
Department High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Max Planck Society;

/persons/resource/persons84187

Scheffler,  K
Department High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Max Planck Society;

/persons/resource/persons214560

Zaiss,  M
Department High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Max Planck Society;

Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Lindig, T., Bender, B., Herz, K., Deshmane, A., Schittenhelm, J., Golay, X., et al. (2020). GLINT GlucoCEST in neoplastic tumours at 3T: the first clinical results of GlucoCEST in brain tumours. Insights into Imaging, 11(Supplement 1): RPS 916-1, 351-352. doi:10.1186/s13244-020-00851-0.


Cite as: https://hdl.handle.net/21.11116/0000-0005-C06C-9
Abstract
There is no abstract available